Schedule Dispatches

This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.

The full Update is available as a PDF(external link)

The changes will be published in the online Schedule around the 23^rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz

September 2025 Pharmaceutical Schedule Dispatch

New Listings

• Aminocaid formula without phenylalanine and tyrosine (TYR Lophlex LQ 20) liquid (juicy berries) 125 ml pouches – Special Authority - Hospital pharmacy [HP3] (p’code 2711443)
• Dipyridamole (Dipyridamole - Strides) cap modified-release 200 mg – section 29 and wastage claimable, and no new patients to be initiated on dipyridamole (p’code 2710919)
• Fexofenadine hydrochloride (Fexaclear) tab 120 mg (p’code 2711222)
• Insulin pump cartridge (Tandem Cartridge) cartridge 300 u, t:lock × 10, 10 OP – Special Authority - Retail pharmacy, maximum of 50 cart per prescription, only on a prescription, maximum of 190 cartridges will be funded per year (p’code 2704188)
• Labetalol (Presolol) tab 200 mg – section 29 and wastage claimable (p’code 2565579)
• Lenalidomide (Viatris) (Lenalidomide Viatris) cap 5 mg – Special Authority - Retail pharmacy (p’code 2707527)
• Levocarnitine (Lacuna) oral liq 1 g per 10 ml, 118 ml – Special Authority - Retail pharmacy, section 29, CBS (p’code 2711281)
• Paroxetine (Paxtine) tab 20 mg (p’code 2600188)
• Remdesivir (Veklury) inj 100 mg vial – PCT only (p’code 2640139)
• Salbutamol (UK Cipla) nebuliser soln, 2 mg per ml, 2.5 ml ampoule – up to 30 neb available on a PSO, section 29 and wastage claimable (p’code 2712199)

Changes to restrictions, chemical names and presentations

• Adalimumab (Amgevita) inj 20 mg per 0.4 ml prefilled syringe, inj 40 mg per 0.8 ml prefilled pen and inj 40 mg per 0.8 ml prefilled syringe – amended Special Authority criteria
• Dipyridamole tab long-acting 150 mg (Pytazen SR) and cap modified-release 200 mg (Dipyridamole – Strides) – addition of note
• Emtricitabine with tenofovir disoproxil (Tenofovir Disoproxil Emtricitabine Viatris) tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate) – amended Special Authority criteria and Subsidy by Endorsement
• Emulsifying ointment (Evara Emulsifying Ointment) oint BP, 500 g – amended brand name
• Ferrous sulfate (Ferrograd) tab long-acting 325 mg (105 mg elemental) – addition of note and removal of stat dispensing
• Melatonin (Vigisom) tab modified-release 2 mg – amended Special Authority criteria
• Meningococcal B multicomponent vaccine (Bexsero) inj 175 mcg per 0.5 ml prefilled syringe – amended funding criteria
• Modafinil (Modafinil Max Health) tab 100 mg – removal of brand switch fee payable
• Oral feed (powder) (Sustagen Hospital Formula) powder (vanilla), 840 g OP – amended brand name
• Rivastigmine patch 4.6 mg per 24 hour (Rivastigmine Patch BNM 5) and patch 9.5 mg per 24 hour (Rivastigmine Patch BNM 10) – amended Special Authority criteria
• Sodium fusidate [fusidic acid] (Fucithalmic Canada (ON) and Fucithalmic Spain) eye drops 1%, 5 g OP – amended brand names

Increased subsidy

Chemical	Presentation	Fully subsidised brands
Abacavir sulphate with lamivudine	Tab 600 mg with lamivudine 300 mg	Abacavir/Lamivudine Viatris
Aciclovir	Tab dispersible 200 mg, 400 mg and 800 mg	Lovir
Amiodarone hydrochloride	Tab 100 mg and 200 mg Inj 50 mg per ml, 3 ml ampoule	Aratac Max Health
Amoxicillin	Cap 250 mg	Miro-Amoxicillin
Atazanavir sulphate	Cap 150 mg and 200 mg	Atazanavir Viatris
Azathioprine	Tab 25 mg and 50 mg	Azamun
Benzatropine mesylate	Tab 2 mg	Benztrop
Capecitabine	Tab 150 mg and 500 mg	Capecitabine Viatris
Cefaclor monohydrate	Cap 250 mg Grans for oral liq 125 mg per 5 ml, 100 ml	Ranbaxy-Cefaclor
Ceftriaxone	Inj 500 mg vial	Ceftriaxone-AFT
Celecoxib	Cap 100 mg	Celebrex
Charcoal	Oral liq 50 g per 250 ml, 250 ml OP	Carbosorb-X
Chloramphenicol	Eye oint 1%, 5 g OP	Devatis
Clobetasol propionate	Crm 0.05%, 30 g OP Oint 0.05%, 30 g OP Scalp app 0.05%, 30 ml OP	Dermol
Clonidine hydrochloride	Tab 25 mcg	Clonidine Teva
Digoxin	Tab 62.5 mcg Tab 250 mcg	Lanoxin PG Lanoxin
Dihydrocodeine tartrate	Tab long-acting 60 mg	DHC Continus
Ferrous sulfate	Oral liq 30 mg (6 mg elemental) per 1 ml, 250 ml	Ferro-Liquid
Glycerol	Suppos 2.8/4.0g	Lax-suppositories Glycerol
Lactulose	Oral liq 10 g per 15 ml, 500 ml	Laevolac
Lidocaine [Lignocaine]	Gel 2%, 11 ml urethral syringe	Instillagel Lido
Loperamide hydrochloride	Cap 2 mg	Diamide Relief
Methadone hydrochloride	Inj 10 mg per ml, 1 ml	AFT
Methotrexate	Inj 5 mg intrathecal syringe for ECP, 5 mg OP	Baxter
Morphine sulphate	Inj 5 mg, 10 mg, 15 mg and 30 mg per ml, 1 ml ampoule	Medsurge
Nicorandil	Tab 10 mg and 20 mg	Max Health
Oral feed (powder)	Powder (chocolate) and (vanilla), 840 g OP	Sustagen Hospital Formula
Oxytocin with ergometrine maleate	Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml ampoule	Syntometrine
Paracetamol with codeine	Tab paracetamol 500 mg with codeine phosphate 8 mg	Paracetamol + Codeine (Relieve)
Paroxetine	Tab 20 mg	Loxamine
Pegfilgrastim	Inj 6 mg per 0.6 ml syringe	Ziextenzo
Phenoxymethylpenicillin (Penicillin V)	Grans for oral liq 125 mg per 5 ml and grans for oral liq 250 mg per 5 ml, 100 ml	AFT
Potassium chloride	Tab long-acting 600 mg (8 mmol)	Span-K
Risedronate sodium	Tab 35 mg	Risedronate Sandoz
Sodium citrate with sodium lauryl sulphoacetate	Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml	Micolette
Sodium chloride	Inj 0.9%, 5 ml ampoule, 10 ml ampoule and 20 ml ampoule	Fresenius Kabi
Sotalol	Tab 80 mg and 160 mg	Mylan
Tamsulosin hydrochloride	Cap 400 mcg	Tamsulosin-Rex
Tenoxicam	Tab 20 mg	Tilcotil
Tetrabenazine	Tab 25 mg	Motetis
Vinorelbine	Cap 20 mg, 30 mg and 80 mg	Vinorelbine Te Arai

Decreased subsidy

Chemical	Presentation	Fully subsidised brands
Ceftriaxone	Inj 1 g vial	Ceftriaxone-AFT
Famotidine	Tab 20 mg	Famotidine Hovid
Zoledronic acid	Inj 0.05 mg per ml, 100 ml, bag	Zoledronic Acid Viatris